Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - OTHER LONG-TERM ASSETS
Other Long-term Assets KROS - Keros Therapeutics, Inc.
2.05 M
LAST VALUE
400.24%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR